News
The most recent news and industry headlines are presented in this section. Our dedicated team closely observes the pharmaceutical industry and keeps you informed of the most recent developments around the Europe.
EU Pharmaceutical Rules Reform Secures Political Deal Boosting Innovation and Access
Tuesday, January 06, 2026The European Commission welcomes the political agreement between the Council and Parliament to modernise over yearold EU pharmaceutical legislation enhancing innovation supply chains and medicine availability
Switzerland to Further Solidify Leadership in European Life Sciences Ecosystem in 2026
Monday, January 05, 2026Switzerland will widen its lead as Europes premier life sciences hub in driven by structural advantages and proximity to Roche and Novartis
JPMorgan Identifies Top EU Pharma, Biotech & Life Science Stocks for 2026 with AstraZeneca Leading Rankings
Friday, January 02, 2026JPMorgan highlights AstraZeneca Novartis Bayer Argenx UCB Zealand Pharma Lonza and others as top performers in European pharma biotech and life sciences for
EU Critical Medicines Act Advances as Parliament Adopts Draft to Strengthen Supply Chains and Reduce Dependencies
Thursday, January 01, 2026The European Parliaments Public Health Committee has adopted a draft bill to boost investment in critical medicines manufacturing and enhance EU supply chain resilience
Europe's Dramatic Decline in Pharmaceutical Production Threatens Health Sovereignty
Tuesday, December 30, 2025Europe faces a critical loss of pharmaceutical manufacturing dominance to China India and the US jeopardizing health sovereignty amid fragmented supply chains and shifting investments
European Commission and Parliament reach landmark political agreement on overhaul of EU pharmaceutical legislation
Monday, December 29, 2025EU institutions have reached a landmark political agreement to overhaul general pharmaceutical legislation reshaping incentives regulatory pathways and manufacturing obligations for companies operating in Europe
EU Unveils Sweeping Reforms for Pharma, Biotech, and Medical Device Sectors to Accelerate Innovation
Friday, December 26, 2025The European Union has announced comprehensive regulatory reforms targeting the pharma biotech and medical device industries to streamline approvals reduce bureaucracy and boost innovation across Europes life sciences sector
Sanofi's Wayrilz Approved in the EU as First BTK Inhibitor for Immune Thrombocytopenia
Thursday, December 25, 2025The European Commission has approved Sanofis Wayrilz rilzabrutinib as the first BTK inhibitor for adult patients with immune thrombocytopenia refractory to other treatments based on phase LUNA study results
Sanofi's Wayrilz Approved in the EU as First BTK Inhibitor for Immune Thrombocytopenia
Wednesday, December 24, 2025The European Commission has approved Sanofis Wayrilz rilzabrutinib as the first BTK inhibitor for adult patients with immune thrombocytopenia refractory to other treatments based on phase LUNA study results
U.S. FDA approves JASCAYD® (nerandomilast) tablets for progressive pulmonary fibrosis in adults
Tuesday, December 23, 2025Boehringer Ingelheim has received approval from the US Food and Drug Administration FDA for JASCAYD nerandomilast tablets to treat adults with progressive pulmonary fibrosis PPF The approval provides a new treatment option in the US for this serious...
